Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01LSB
|
|||
| Former ID |
DNCL003538
|
|||
| Drug Name |
MEMP1972A
|
|||
| Synonyms |
RG7449
Click to Show/Hide
|
|||
| Indication | Allergic rhinitis [ICD-11: CA08.0] | Phase 2 | [1] | |
| Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Phase 2 | [1] | ||
| Company |
Genentech
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Immunoglobulin E (IgE) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01582503) A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA). U.S. National Institutes of Health. | |||
| REF 2 | International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 25, No. 4, 2011 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.